
Small molecules with great potential: An exciting advance in type 1 diabetes research
Sophie Basarrate reports on two new studies which suggest that pancreatic B cells may regenerate, and the applications it has for diabetes.
Sophie Basarrate reports on two new studies which suggest that pancreatic B cells may regenerate, and the applications it has for diabetes.
Ayush Sinha examines metformin’s role in longevity and reports on the highly-anticipated TAME trial set to further investigate its potential.
Isabelle Goodall-Summers explores the off-label use of Ozempic for weight loss, highlighting potential societal implications.
Emma Clarke reports on new research showing that blocking the enzyme glucokinase may slow, or even prevent, type 2 diabetes disease progression.
Megan Perry discusses how the body knows the time, and the role a poor sleep cycle plays in insulin secretion and developing diabetes.
Obesity is clinically defined when someone’s Body Mass Index (BMI) exceeds 30. It is a metabolic disorder where by energy intake from food and drinks exceeds energy consumption from metabolism and physical activities. There are many health-related risks associated with obesity, especially for children. This includes increased susceptibility for type II diabetes, cardiovascular diseases, and…